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Abstract
Background: β-carotene 15,15'-monooxygenase (BCMO1) catalyzes the crucial first step in
vitamin A biosynthesis in animals. We wished to explore the possibility that a carbocation
intermediate is formed during the cleavage reaction of BCMO1, as is seen for many isoprenoid
biosynthesis enzymes, and to determine which residues in the substrate binding cleft are necessary
for catalytic and substrate binding activity. To test this hypothesis, we replaced substrate cleft
aromatic and acidic residues by site-directed mutagenesis. Enzymatic activity was measured in vitro
using His-tag purified proteins and in vivo in a β-carotene-accumulating E. coli system.
Results: Our assays show that mutation of either Y235 or Y326 to leucine (no cation-π
stabilization) significantly impairs the catalytic activity of the enzyme. Moreover, mutation of Y326
to glutamine (predicted to destabilize a putative carbocation) almost eliminates activity (9.3% of wt
activity). However, replacement of these same tyrosines with phenylalanine or tryptophan does not
significantly impair activity, indicating that aromaticity at these residues is crucial. Mutations of two
other aromatic residues in the binding cleft of BCMO1, F51 and W454, to either another aromatic
residue or to leucine do not influence the catalytic activity of the enzyme. Our ab initio model of
BCMO1 with β-carotene mounted supports a mechanism involving cation-π stabilization by Y235
and Y326.
Conclusions: Our data are consistent with the formation of a substrate carbocation intermediate
and cation-π stabilization of this intermediate by two aromatic residues in the substrate-binding
cleft of BCMO1.
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Carotenoid polyene oxygenases are a diverse superfamily
whose members play a crucial role in carotenoid/retinoid
metabolism, producing, among other actions, key hor-
mones such as abscisic acid in plants [1] and vitamin A in
animals [2]. Three mammalian family members with very
different functions have been described: 1) β-carotene-
15,15'-monooxygenase (BCMO1)1 is an enzyme which
symmetrically cleaves β-carotene to produce two mole-
cules of all-trans retinal [3], and is the initial step in bio-
synthesis of vitamin A in animals [2,4]; 2) β-carotene-
9',10'-monooxygenase (BCMO2) is believed to cleave β-
carotene asymmetrically to produce 10'-apocarotenal and
β-ionone [5]; and 3) RPE65 is an isomer(ohydrol)ase in
the visual cycle, converting all-trans retinyl palmitate to
11-cis retinol [6-8]. In BCMO1 knockout mice, disruption
in BCMO1 leads to hypercarotenemia on a provitamin A-
rich, vitamin A-deficient diet and also to changes in lipid
metabolism and susceptibility to diet-induced obesity [9].
Pathological effects of mutations in BCMO1 [10] have
also been described in humans. Therefore, the catalytic
mechanism for this enzyme is of particular interest.
Based on the solved apocarotenoid-15,15'-oxygenase
(ACO) crystal structure, all these iron (II)-dependent oxy-
genases are predicted to share a common seven bladed β-
propeller structure [11]. In ACO, Fe(II) is coordinated in
a near-perfect octahedral arrangement by four histidines.
The fifth position in the crystal structure is occupied by a
water molecule, and dioxygen is proposed to complete the
coordination geometry at the sixth position. Presumably,
all members of this family, including BCMO1, share this
iron center arrangement. Recently, we validated the crystal
structure predictions by showing that mutations of the
invariant histidines H172A, H237A, H308A and H514A
which are paralogs of the iron-coordinating histidines in
ACO abolished BCMO1 activity. Although still controver-
sial, the central cleavage of β-carotene by BCMO1 is cur-
rently believed to follow a monooxygenase mechanism
[12]. On the other hand, it has unequivocally been shown
that the plant family member CCD1 is a dioxygenase [13].
Experiments by Olson et al. with crude enzyme prepara-
tions led the authors to believe that BCMO1 is also a diox-
ygenase [14,15]. However, the substituted bis(1-
alkylimidazol-2-yl)propionate mononuclear iron com-
plexes, which closely resemble ACO iron coordination,
efficiently catalyze both olefin epoxidation (monoxygen-
ation products) and cis-dihydroxylation (dioxygenation
products) [16], suggesting that both mechanisms are
plausible for the various carotenoid oxygenases.
The process of monooxygenation is suggested to involve
reductive oxygen activation at metal complexes followed
by oxygen transfer to the substrate [17]. In the ACO crystal
structure, all-trans carotenoid substrate was modeled in a
13,14-13',14'-di-cis conformation [11]. The formation of
cation intermediates in the process of trans- to cis-isomer-
ization is well documented for electrochemical, ferric
oxide and iodine oxidation of carotenoids [18-20]. Also,
cationic intermediates were predicted in an ab initio study
of lycopene isomerization, providing a quantum mechan-
ical explanation for the antioxidant properties of caroten-
oids [21]. Recently it has been demonstrated that a
carotenoid cation-radical is formed in the photosynthetic
light harvesting system [22,23]. In addition, the analysis
of the ACO oxidative cleavage mechanism by the quan-
tum chemical density field theory method predicted for-
mation of a substrate radical cation [24]. A cation-radical
is formed by one electron oxidation of β-carotene; a sec-
ond one-electron oxidation leads to formation of a dica-
tion β-carotene. Electron paramagnetic resonance (EPR)
and electrochemical studies of carotenoid oxidation led to
a proposed equilibrium between radical cation, dication
and the original carotenoid. Moreover, careful analysis of
the electrochemical behavior of β-carotene in methylene
chloride demonstrated that two electrons are transferred
in the first oxidation step, and thus formation of dications
occurs at lower oxidation potential [20]. Simultaneous
electrochemical/EPR experiments showed subsequent
decay of the β-carotene dication to a monocation as a
result of the proton transfer [20]. On the other hand, car-
bocation could be produced by protonating the β-caro-
tene carbon-carbon double bond chain. Diamagnetic
carbocations exhibit considerable stability at room tem-
perature due to charge delocalization [25]. A large body of
published work points to stabilization of carbocations by
anionic and aromatic residues in active sites of polyene
chain synthesizing enzymes [26-28]. Recently, an
intramolecular proton-transfer mechanism has been
implicated in a carbocationic mechanism of farnesyl pyro-
phosphate synthase and aristolochene synthase [29,30].
Therefore we have investigated the question of involve-
ment of carbocation intermediates during the enzymatic
cleavage of β-carotene.
In the present report, we have analyzed the role of con-
served catalytic site aromatic residues in the catalytic
mechanism of BCMO1, using site-directed mutagenesis to
create a set of mutant enzymes and characterizing these
mutants using in vitro and in vivo assays.
Results
Modeling of mouse BCMO1 on the ACO template and 
identification of conserved aromatics in the substrate 
binding cleft
Preliminary ClustalW 1.74 alignment of BCMO1 and
ACO was optimized for conserved histidines and acidic
residues. This alignment was iteratively presented to the
Swiss Model Repository with manual adjustment after
each cycle for the final complete model. The alignmentPage 2 of 13
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regions near the Fe-coordinating histidines (Fig. 1). Both
these enzymes cleave carotenoids at the 15-15' position.
Using this alignment to model the structure of BCMO1
(Fig. 2A) we found four aromatics within the substrate
cleft paralogous to aromatics in ACO: F51 (ACO = F69) in
the highly conserved FDG motif above the Fe, Y235 (ACO
= F236) above E140 fixing the second coordinating histi-
dine (H237), Y326 (ACO = Y322) above E405 fixing the
third coordinating histidine (H308), and W454 (ACO =
W423) near E457 fixing the fourth coordinating histidine
(H514) (Fig. 2B). F51, Y235 and Y326 are predicted to be
less than 5 Å from the polyene chain of the substrate, and
W454 is similarly close to one of the β-ionone rings of the
substrate (Fig. 2C).
To determine the role of these aromatic residues and the
nearby acidic residues in the catalytic mechanism of
BCMO1, we constructed a set of mutants in which each of
these aromatic residues was replaced with leucine or an
alternative aromatic. Y326 was also exchanged to the par-
alogous glutamine, as in BCMO2. In previous work, we
had determined the effect of mutating the conserved
acidic residues to alanine [31].
Analysis of aromatics in the substrate binding cleft in vivo
Since mutation of the crucial residues in the enzyme leads
to significant reduction in the activity of BCMO1, the sen-
sitivity of in vitro enzymatic assay is not sufficient for anal-
ysis of these residues[32]. Therefore, we made use of β-
carotene-accumulating E.coli/pAC-BETA [33] as an in vivo
system for measurement of enzymatic activity.
Substrate for BCMO1 (β-carotene) is constitutively syn-
thesized and accumulated in this specially designed E.coli
strain. After we allowed sufficient time for β-carotene to
be accumulated in the cells, we induced synthesis of
BCMO1 and measured the amount of beta-carotene left in
induced and uninduced cells. As previously described
[31], uninduced pBAD/BCMO1 constructs are function-
ally equivalent to the irrelevant pBad/LacZ construct (in
which there is no carotene cleavage) for use as negative
controls of BCMO1 activity.
Mutation of either F51 or W454 to leucine had little effect
on the activity of BCMO1 and mutation of F51 to tyrosine
or W454 to phenylalanine had no effect in this assay (Fig.
3A, B). However, a more significant effect was seen with
the two tyrosines, Y235 and Y326. In the case of Y235,
practically no loss of activity was observed with the
Y235W mutant, moderate loss of activity with the Y235F
mutant, and greater loss with the Y235L mutant (Fig. 3C).
Y235 is located adjacent to the E140 "fixing" glutamate in
the substrate binding cleft (~3.8 A), for which the E140A
mutation has been shown to reduce activity to about 50%
relative to WT [31]. Thus, these two residues could play a
role in the catalytic mechanism of the enzyme. Analysis of
the double mutants for Y235F/E140A and Y235L/E140A
revealed residual activity (bleaching) only for Y235F/
E140A mutant 20 h post-induction (data not shown).
These results support the idea that this pair is not involved
in proton transfer for formation of carbocations but may
point to compensating mechanisms in substrate stabiliza-
tion. As we noted above, Y326 is located on our model
less than 5 Å from β-carotene and 2.73 Å from E405. To
address the function of Y326 in the BCMO1 catalytic
mechanism, we constructed a set of mutants: Y326W (as
in RPE65), Y326F, Y326L and Y326Q (as in BCMO2).
Catalytic activity of Y326W (84.2 ± 5.4) is comparable to
that of the wild type BCMO1 (82.4 ± 5.6) in the accumu-
lative in vivo system (Fig. 3D) and Y326F is also active.
Mutation to the nonaromatic amino acid leucine, Y326L,
resulted in a drop in catalytic activity (38.2 ± 2.6). The
most significant decrease in catalytic activity was observed
by introduction of the partially positively charged amino
acid glutamine in place of tyrosine: Y326Q (9.3 ± 1.5).
(Fig. 3D). Our previous studies had demonstrated that, of
the three "fixing" glutamates, only E405 is indispensable
for enzyme activity as the E405A mutant has no activity,
although the protein is expressed [31]. Thus, compensat-
ing mechanisms are unlikely for this pair of residues.
These data collectively demonstrate that aromaticity of the
residue is important for the enzyme activity in both the
Y235 and Y326 positions but not in the F51 or W454
positions.
Expression of mutant constructs
To examine the correlation of enzyme activity with in vivo
protein expression levels for the various mutants, immu-
noblots of extracts from 10 cell lines transformed with
mutant BCMO1 constructs were analyzed by His-tag and
rabbit polyclonal BCMO1 specific antibodies (Fig. 4A, B).
Endogeneous EF-Tu bacterial protein (MW = 49,541Da)
was used as a loading control. When compared with
wildtype, the drastic decrease in mutant enzyme activity
observed in vivo correlated with somewhat lowered
expression levels, but these changes in activity could not
be explained solely by a change in expression levels.
In vitro analysis of enzymatic activity of BCMO1 tyrosines
In our in vitro assay system we determined Km and Vmax for
Y326W, and two mutants on the propeller axis, Y418F
and Y420F. Tyrosines 418 and 420 are fairly well con-
served among mammal family members and are located
far from the catalytic site of the enzyme. In Y326W, we
observed a 4-fold decrease in Vmax and 4-fold increase in
Km, whereas Y420 F did not show significant changes in
kinetics and Y418F shows 3-fold decrease in Vmax and only
2-fold increase in Km (Table 1). We were unable to deter-
mine kinetics for the Y235F mutant due to insufficientPage 3 of 13
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ClustalW protein sequence alignment of murine polyene oxygenase family members with ACOFigure 1
ClustalW protein sequence alignment of murine polyene oxygenase family members with ACO. Conserved 
iron-coordinating residues are in bold black, conserved tyrosines in bold blue and the acidic residues of the signature sequence 
in bold red. Nonconserved aromatics studied are in blue. The last 4 amino acids of mouse BCMO1 were removed. Gen-
Bank™/EBI accession numbers are as follows: mouse BCMO1, AF271298; mouse BCMO2, AJ290392; mouse RPE65, 
NM_029987; Synechocystis LSD (ACO), D90914. Alignment coding: * identity, : strong similarity, weak similarity.
mouse_BCMO1      ------------------MEIIFGQNKKEQLEPVQAKVTGSIPAWLQGTLLRNGPGMHTV 
mouse_BCM02      ---------MLGPKQSLPCIAPLLTTAEETLSAVSARVRGHIPEWLNGYLLRVGPGKFEF 
mouse_RPE65      --------MSIQIEHPAGGYKKLFETVEELSSPLTAHVTGRIPLWLTGSLLRCGPGLFEV 
ACO              MVTSPPTSSPSQRSYSPQDWLRGYQSQPQEWDYWVEDVEGSIPPDLQGTLYRNGPGLLEI 
                                          .  :  .     * * **  * * * * ***   . 
                        51 
mouse_BCMO1      GESKYNHWFDGLALLHSFSIR-DGEVFYRSKYLQSDTYIANIEANRIVVS-EFGTMAYPD
mouse_BCM02      GKDRYNHWFDGMALLHQFRME-RGTVTYKSKFLQSDTYKANSAGGRIVIS-EFGTLALSD
mouse_RPE65      GSEPFYHLFDGQALLHKFDFK-EGHVTYHRRFIRTDAYVRAMTEKRIVIT-EFGTCAFPD
ACO              GDRPLKHPFDGDGMVTAFKFPGDGRVHFQSKFVRTQGYVEEQKAGKMIYRGVFGSQPAGG
                 *.    * *** .::  * :   * * :: :::::: *       :::    **: .  . 
mouse_BCMO1      PCKNIFSKAFSYLSHTIPDFTDNCLINIMKCGEDFYATTETNYIRKIDPQTLETLEKVDY
mouse_BCM02      PCKSIFERFMSRFEP--PTMTDNTNVNFVQYKGDYYMSTETNFMNKVDIEMLERTEKVDW
mouse_RPE65      PCKNIFSRFFSYFKG--VEVTDNALVNIYPVGEDYYACTETNFITKINPETLETIKQVDL
ACO              WLKTIFDLRLKNIAN----------TNITYWGDRLLALWEGGQPHRLEPSNLATIGLDDL
                   *.**.  :. :             *:           * .   ::: . *      *
mouse_BCMO1      RKYVAVN-LATSHPHYDEAGNVLNMGTSVVDKGRTKYVIFKIPATVPDSKKKGKSPVKHA
mouse_BCM02      SKFIAVN-GATAHPHYDPDGTAYDMGNSYGPRGSCYNIIR-----VPPKKKEPGETIHGA
mouse_RPE65      CNYISVN-GATAHPHIESDGTVYNIGNCFGKNFTVAYNIIK----IPPLKADKEDPINKS
ACO              GGILAEGQPLSAHPRIDPASTFDGGQPCYVTFSIKSSLSST----------LTLLELDPQ
                    :: .   ::**: :  ..  .   .                            :.
                               235 
mouse_BCMO1      EVFCSISSRSLLSPSYYHSFGVTENYVVFLEQPFKLDILKMATAY-MRGVSWASCMSFDR
mouse_BCM02      QVLCSIASTEKMKPSYYHSFGMTKNYIIFVEQPVKMKLWKIITSK-IRGKPFADGISWEP
mouse_RPE65      EVVVQFPCSDRFKPSYVHSFGLTPNYIVFVETPVKINLFKFLSSWSLWGANYMDCFESNE
ACO              GKLLRQKTETFPGFAFIHDFAITPHYAIFLQNNVTLNGLPYLFGLRGAG----ECVQFHP
                   .           :: *.*.:* :* :*::  ..:.      .    *    . .. .
                                                               326 
mouse_BCMO1      EDKTYIHIIDQRTRKPVPTKFYTDPMVVFHHVNAYEEDGCVLFDVIAYE-DSSLYQLFYL
mouse_BCM02      QYNTRFHVVDKHTGQLLPGMYYSMPFLTYHQINAFEDQGCIVIDLCCQD-DGRSLDLYQL
mouse_RPE65      SMGVWLHVADKKRRKYFNNKYRTSPFNLFHHINTYEDNGFLIVDLCCWKGFEFVYNYLYL
ACO              DKPAQIILVPRDGGEIKRIPVQAG--FVFHHANAFEENGKIILDSICYN-----------
                 .  . : :  :   :       :     :*: *::*::* ::.*  . .
mouse_BCMO1      ANLNKDFE---EKSRLTSVPTLRRFAVPLHVDKDAEVGSNLVKVSSTTATALKEKDGHVY 
mouse_BCM02      QNLRKAGEGLDQVYELKAKSFPRRFVLPLDVSVDAAEGKNLSPLSYSSASAVKQGDGEIW 
mouse_RPE65      ANLRENWEEVKRNAMKAPQPEVRRYVLPLTIDKVDT-GRNLVTLPHTTATATLRSDETIW 
ACO              -----------------SLPQVDTDGDFRSTNFDNLDPGQLWRFTIDPAAATVEKQLMVS 
                                  . .           .       :*  ..  .*:*  . :  :
                                               418
mouse_BCMO1      CQPEVLYE-------GLELPRINYA-YNGKPYRYIFAAEVQW---SPVPTKILKYDILT-
mouse_BCM02      CSPENLHHEDLEEEGGIEFPQINYGRFNGKKYSFFYGCGFR----HLVGDSLIKVDVTN-
mouse_RPE65      LEPEVLFSGPRQ---AFEFPQINYQKFGGKPYTYAYGLGLN----HFVPDKLCKMNVKT-
ACO              R--------------CCEFPVVHPQ-QVGRPYRYVYMGAAHHSTGNAPLQAILKVDLESG
                                  *:* ::    .*:** : :        .      ::* ::
                           454 
mouse_BCMO1      KSSLKWSEESCWPAEPLFVPTPGAKDEDDGVILSAIVST-DPQKLPFLLILDAKSFTELA
mouse_BCM02      KTLRVWREEGFYPSEPVFVPVPGADEEDSGVILSVVITP-NQSESNFLLVLDAKSFTELG
mouse_RPE65      KEIWMWQEPDSYPSEPIFVSQPDALEEDDGVVLSVVVSPGAGQKPAYLLVLNAKDLSEIA
ACO              TETLRSFAPHGFAGEPIFVPRPGGVAEDDGWLLCLIYKADLHRSELVILDAQDITAPAIA
                            :..**:**. *..  **.* :*. : ..    .   :*  :    . :. 
mouse_BCMO1      RASVDADMHLDLHGLFIPDADWNAVKQTPAETQEVENSDHPTDPTAPELSHSENDFTAGH
mouse_BCM02      RAEVPVQMPYGFHGTFVPI-----------------------------------------
mouse_RPE65      RAEVETNIPVTFHGLFKRS-----------------------------------------
ACO              TLKLKHHIPYPLHGSWAQT-----------------------------------------
                   .:  .:   :** :
BMC Biochemistry 2009, 10:31 http://www.biomedcentral.com/1471-2091/10/31sensitivity of the in vitro assay used in our studies here,
although at the highest substrate concentration techni-
cally possible in this assay system, a low level of activity
was observed (data not shown). This suggests a probable
increase in Km for the Y235F mutant. Also, the substantial
increase in Km observed only in the substrate cleft residues
supports the hypothesis that they play a role in substrate
stabilization. Neighboring to Y235, the Y236F mutant
showed also about a 3 fold increase in Km and a more pro-
nounced 5 fold decrease in Vmax. Expression of the Y236L
mutant was almost abolished (5% of wt BCMO1) in our
system, and this fact points to a possible structural role for
this residue.
Diphenylamine is an inhibitor of BCMO1
Many enzymes involving a transient carbocation mecha-
nism are effectively inhibited by positively charged amine
derivatives [34-36]. The inhibitory potency of these amine
PyMol modeling of BCMO1 on the ACO templateFigure 2
PyMol modeling of BCMO1 on the ACO template. A) Aromatic residues in the binding cleft of BCMO1. Selected aro-
matic residues of BCMO1 are plotted to equivalent positions on the carbon backbone of the ACO crystal structure [11] by 
using the PyMol program. Blue, aromatics side chains; red, backbone oxygen; blue, backbone nitrogen; dark pink, iron center; 
gold, beta-carotene. B) Visualization of the aromatic and acidic BCMO1 residues of the catalytic site on the ACO crystal struc-
ture. Aromatic residues of the substrate binding region modeled on the ACO template (PyMol) are shown. Violet, aromatic 
side chains; pink, acidic side chains; green, iron-coordinating histidines side chains; red, backbone oxygen; blue, backbone nitro-
gen; red-pink, iron center; gold, beta-carotene. C) Model of the tyrosines and acidic residues in the substrate binding cleft of 
BCMO1. PyMol model of BCMO1 (tyrosines and "fixing" glutamates in radius <5 Å from β-carotene are shown) on apocarote-
noid oxygenase (ACO) template with ab initio mounted β-carotene. A possible hydrogen bond is predicted between Y326/
E405.Page 5 of 13
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B-carotene cleavage activity of mutants of aromatic residues located in binding cleft of BCMO1Figure 3
B-carotene cleavage activity of mutants of aromatic residues located in binding cleft of BCMO1. A) Mutations of 
F51. B) Mutations of W454. C) Mutations of Y235. D) Mutations of Y326. Mid-log phase cultures of β-carotene producing E. 
coli transformed with pBAD/BCMO1 (+ control) or pBAD/mutant BCMO1 constructs were split in half; one half was induced 
with 0.02% L-arabinose, while the other was not. Both cultures were grown for 3 hours at 30°C in the dark and harvested. β-
carotene was extracted and analyzed by RP-HPLC. To account for differences in the production of β-carotene in various cell 
cultures prior to induction we expressed β-carotene cleavage activity as (1-n) × 100%, where n is a ratio of β-carotene 
extracted from induced culture to β-carotene extracted from uninduced cell culture, normalized to protein concentration (+/-
SE, N = 3).
BMC Biochemistry 2009, 10:31 http://www.biomedcentral.com/1471-2091/10/31derivatives is linked to their ability to be protonated at
physiological pH (noncompetitive inhibition) [34] or to
their similarity to transition state carbocation intermedi-
ates (competitive inhibition). To further elucidate the
mechanism of action of BCMO1, we examined the effects
of various amine inhibitors of carotenoid synthesis such
as nicotine (gamma and beta cyclases) [34], galactos-
amine (xanthophyll epoxidase) [36] and diphenylamine
(phytoene desaturase and β-carotene ketolase) [37] on
enzyme activity. Neither nicotine nor galactosamine sig-
nificantly inhibited BCMO1 (data not shown); however,
diphenylamine inhibited BCMO1 at sub-millimolar con-
centrations in vitro (Fig. 5A) Diphenylamine, which inhib-
its carotenoid synthesis completely at 200 μM
concentration [38] also impaired β-carotene degradation
significantly our in vivo assay in β-carotene-accumulating
E.coli expressing BCMO1 (Fig. 5B).
Discussion
In multiple protein sequence alignment of vertebrate car-
otenoid oxygenase family member sequences (Fig. 1), we
found that all members conserved aromatics in positions
comparable to F51, Y235, and W454. With respect to
Y326 in BCMO1, Y was conserved in other BCMO1
orthologs, W was the paralogous residue in RPE65, but
aromatic resides were not found in BCMO2 sequences at
this position. It should be noted that BCMO1 and RPE65
both act at the 15 carbon position, whereas BCMO2 is
thought to cleave carotenoids asymmetrically. The Swiss-
Expression of mutant BCMO1 constructs in transformed cell linesFigure 4
Expression of mutant BCMO1 constructs in transformed cell lines. A) Quantification of expression of F51 and W454 
mutants. B) Quantification of expression of Y235 and Y326 mutants. The cell extracts were probed with a monoclonal anti-His 
antibody. The intensity of each mutant BCMO1 band was quantified by densitometry and normalized to intensity of recom-
binant BCMO1 (0.1 μg) synthesized by Roche RTS cell-free transcription/translation on each gel.
Table 1: Biochemical Characteristics of wt BCMO1 and 
enzymatically active mutantsa.







aKm [μM] and Vmax [pmol retinal/hour* μg enzyme] were calculated 
from Hanes [s/v vs s] plots. Calculation of enzymatic activity was 
based on the production of retinal from β-carotene. Data was 
calculated based on average substrate curve for each protein.
# These data are Km apparent values due to limitations of β-carotene 
solubility in reaction mixture (the highest concentration of β-carotene 
is 42 μM).Page 7 of 13
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dicts that F51, Y235, Y326 and W454 are aromatics
located in the carotenoid binding cleft. The possibility
that some or all of these residues participate in catalyti-
cally important functions was thus an important consid-
eration. Tyrosines are known to play a key role in coupled
proton-shuttling in a large number of metalloenzymes
[39,40], and, additionally, can directly participate in elec-
tron transfer by forming tyrosyl radicals [41,42]. They
may also play a structural role by participating in the
architecture of the enzyme active site, or play a role in the
correct positioning of the substrate and cofactor [43,44]
and are known to take part in interaction with substrate
and/or cofactors and determine the substrate specificity in
a variety of enzymes [44-47]. Finally, tyrosine and other
aromatic amino acids are implicated in cation-π interac-
tions stabilizing carbocation intermediates generated dur-
ing enzymatic reactions [27,48,49].
Our results indicate that mutations of Y235 and Y326 to
leucine significantly impair catalytic activity of BCMO1.
We found that the aromaticity of amino acids Y235 and
Y326 are important for enzymatic activity, whereas muta-
tion of F51 or W454 to leucine had little effect. Mutation
of either of these two tyrosines to other aromatic residues
(phenylalanine or tryptophan) does not affect enzyme
activity by more than 10-20% relative to wild type, but
replacement to non-aromatic residues (leucine or
glutamine) leads to significant loss of enzymatic activity.
The studies presented here support a mechanism implicat-
ing cation-π stabilization of a putative carbocation inter-
mediate. We can exclude the possibility of radical
formation by these tyrosines in BCMO1 catalysis, as the
tyrosine to leucine mutants, Y235L and Y326L, although
reduced in activity (sometimes significantly), exhibited
some level of residual activity. Additionally, EPR analyses
of BCMO1 failed to detect tyrosyl radical formation
(Poliakov and Krishna, unpublished results). However,
this finding does not exclude the possibility of other func-
tional roles for these residues. The Swiss-PDB model of
BCMO1 built on the ACO template predicts close locali-
zation of Y235-E140 and Y326-E405 residues with possi-
ble hydrogen bonding for the latter pair (~2.73 Å) (Fig.
2B). However, our mutagenesis data suggest that these
Inhibition of BCMO1 by diphenylamineFigure 5
Inhibition of BCMO1 by diphenylamine. A) Inhibition of BCMO1 by diphenylamine in vitro. Diphenylamine (50-1000 μM) 
was added from a 20 mM stock in DMSO to an in vitro reaction mixture prior to addition of substrate. The final concentration 
of DMSO in all samples was 5%. The enzyme was preincubated with the inhibitor for 30 min at 4°C in the standard reaction 
buffer and was then added to 20 μM β-carotene and activity determined as described in Methods. A representative experiment 
is shown. B) Inhibition of BCMO1 by diphenylamine in vivo. E. coli cultures transformed with both the plasmid for β-carotene 
synthesis and the BCMO1 plasmid were grown overnight (12-16 hr) to allow accumulation of β-carotene. At this point, the 
inhibitor diphenylamine (at a final concentration of 200 μM from a 200 mM stock solution in MeOH) was added to prevent fur-
ther synthesis of carotenoids [38]. The cultures were shaken for 2 hours, split in half, and one half was induced by the addition 
of arabinose (0.02% final concentration). Both cultures were shaken for an additional 7 hours and analyzed by the in vivo assay 
as described in Methods (N = 3).Page 8 of 13
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anism of BCMO1; moreover, simultaneous replacement
of Y235F/E140A does not eliminate activity.
From our data it is reasonable to propose that aromaticity
of the two tyrosines Y235 and Y326 plays an important
role in the catalytic mechanism of BCMO1. To explore
this possibility, we mounted an ab initio model of β-caro-
tene onto the BCMO1 structural model by thermody-
namic optimization. It was observed that tyrosines Y235
and Y326 fix the position of the substrate on two sides of
the 15-15' double bond of the substrate (Fig. 2C). The pre-
dicted hydrophobic interactions with substrate are in
accordance with our catalytic activity data for Y235F,
Y235W and Y235L, and Y326W, Y326F and Y326L
mutants. Consequently, we can speculate that in the case
of a mechanism involving one-electron oxidation by diox-
ygen bound to the ferrous ion and the subsequent radical-
cation formation [24], or two one-electron oxidation
steps and dication formation [20], the aromatic residues
(Y235, Y326) and glutamates (E140, E405) stabilize a cat-
ionic intermediate with charge delocalization along the
polyene chain. On the other hand, we could not rule out
the possibility of protonation of a double bond and for-
mation of a carbocation as in the case of isopentyl diphos-
phate:dimethylallyl diphosphate isomerase [48].
Distances between these tyrosines and β-carotene chain in
our model are less that 5 Å which is in good agreement
with cation-π stabilization (Fig. 2C) [50]. The occurrence
of such stabilization was previously observed in squalene-
hopene cyclase and oxidosqualene-lanosterol cyclase
[26,27]. In the polycyclization cascade of squalene and
oxidosqualene, aspartates initiate the cyclization process
by protonation of the terminal double bond and stabilize
the first carbocation intermediate [28]. The π-electrons of
several aromatic residues stabilize cationic intermediates
in other enzymes [49,51,52]. The cation intermediate
would explain the observation of transient substrate
isomerization in the binding cleft of ACO [11]. Transient
carbocations are formed in many steps of sterol and caro-
tenoid synthesis, and various positively charged amino
derivatives could noncompetitively inhibit these
enzymes. Of the three inhibitors tested here, diphe-
nylamine, an oxidation inhibitor, was the only one to
have a substantial inhibitory effect on BCMO1 activity.
Diphenylamine is reported to inhibit electron transfer in
photosynthetic membranes [53] and carotenogenesis by
inhibiting carotenoid ketolase and phytoene desaturase.
However, this is in line with the common mechanism of
inhibition by diphenylamine of iron oxygenases and is
not necessarily conclusive for carbocation formation.
As expected, replacement of Y326 by tryptophan, which
has the highest π-binding energy of the aromatic series
[54], did not negatively effect activity in vivo. The altered
biochemical parameters (especially the higher Km) for the
Y326W mutant could be explained by steric hindrance.
Also, it is important to note that the in vivo assay shows
the cumulative effect of mutation and thus cannot esti-
mate the catalytic efficiency of the enzyme. Replacement
of tyrosine by glutamine (a partially positively charged
residue)[55] would be expected to destabilize a cation,
and therefore, effectively inhibit catalytic activity of
BCMO1. The results presented here correlate with these
hypotheses. Productive replacement of Y326 by tryp-
tophan, such as found at the paralogous residue W331 in
RPE65 [56] suggests that BCMO1 and RPE65 may share a
similar catalytic mechanism. In fact, the formation of a
carbocation intermediate had been proposed in the cata-
lytic mechanism of retinoid isomerization in the RPE
[57,58] prior to the identification of RPE65 as the isomer-
ase [6-8].
Conclusions
We show that aromaticity of the substrate binding cleft
aromatic residues Y235 and Y326 is important for the
activity of recombinant mouse BCMO1. The enzymatic
activity changes follows the trend Y235W>Y235F>Y235L
and Y326W~Y326F>Y326L>Y326Q which agrees very
well with the π-binding energies of these amino acids.
Based on the mutational data and structure modeling we
propose that cation-π interactions between Y235 and
Y326 and β-carotene cation intermediate play an impor-
tant role in the mechanism of BCMO1. We also show that
replacing F51 and W454, two other substrate binding cleft
aromatic residues, does not affect BCMO1 enzyme activ-
ity. Insight into the mechanism of BCMO1 would help to
understand carotenoid levels and metabolism in humans
[59].
Methods
Site-directed mutagenesis and expression of the mouse 
BCMO1, and mutants
A panel of mutant mouse BCMO1 proteins was made
using a previously described pBAD/BCMO1 construct
containing the BCMO1 open-reading frame as template
[4]. Site-directed mutagenesis of these proteins was done
with the QuikChange XL site-directed mutagenesis kit
(Stratagene, CA). The validity of all point mutations and
the integrity of the open reading frames were verified by
sequencing.
Wild-type BCMO1 and single point mutants containing a
polyHis-tag fusion were expressed in a carotenoid-accu-
mulating strain of E.coli or in TOP10 strain of E.coli as
described previously [31].
In vivo assay of enzymatic activity of the mouse BCMO1 
and mutants
pBAD/BCMO1, pBAD/mutant BCMO1 or pBAD/LacZ
expression constructs were transformed into competent
cells prepared as described [60] from a strain of E.coliPage 9 of 13
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accumulates β-carotene [33]. Overnight cultures of E.coli/
pAC-BETA with constructs were grown in LB broth supple-
mented with 100 μg/mL ampicillin and 30 μg/mL chlo-
ramphenicol at 30°C. One ml of the overnight culture
was used to inoculate 50 mL of LB broth supplemented
with the same antibiotics. The culture was allowed to
grow at 37°C to mid-log phase (OD600~0.6) and was then
split; one half was induced with 0.02% (w/v) of arabinose
while the other was not induced. Both cultures were
grown for another 3 hours at 30°C, optical density meas-
ured, and cells were collected by centrifugation at 5,000 g
for 20 min. Pellets were frozen in dry ice and stored at -
70°C. To quantify the activity of the various constructs,
carotenoids were extracted from frozen bacterial cultures.
Small aliquots (2 mL) were frozen for protein determina-
tions and western blotting. The pellet was resuspended in
acetone with 2.7% formaldehyde and 3% methanol (1
mL) containing β-8'-apo-carotenal (30 μM) as an internal
standard. Cells were resuspended by sonication and vor-
texing and then were divided into three equal aliquots and
each was centrifuged for 2 min at 16,060 g. Supernatants
were collected, and carotenoids were extracted from each
pellet with 2 sequential aliquots of 300 μL acetone with
rigorous vortexing. Supernatants and acetone extracts
were combined and filtered, and then 100 μL was injected
onto a reverse phase HPLC (RP-HPLC) column (see
below). The amount of β-carotene was quantified as the
area of peak normalized to the area of the β-8'-apo-carote-
nal internal standard. Samples were assayed in triplicate
from induced and uninduced cultures and the activity
expressed as a (1-n) × 100%, where n is a ratio of β-caro-
tene extracted from induced culture to β-carotene
extracted from uninduced cell culture, normalized to pro-
tein concentration (+/-SE, N = 3).
Immunoblotting
Mid-log phase cultures of E.coli were induced with 0.02%
L-arabinose, grown for 3 hours at 30°C in the dark and
harvested. The cell cultures (2 mL, OD~1.7), were resus-
pended in 200 μL of 50 mM Tris-HCl (pH 8), 300 mM
NaCl solution with Complete Mini EDTA-free protease
inhibitors (Roche, 1 tab/10 mL) and homogenized using
the FastPrep device (QBiogen) according to the manufac-
turer's recommendations. Due to the restricted amount of
available protein, equivalent protein from 3 extracts of a
mutant was pooled for each mutant sample. 25 μg of total
lysate protein was loaded per lane on the gel. The blots
were probed with monoclonal anti-His antibodies
(Roche) diluted 1:1,000 in 5% BSA in IBS for 1 hour, and
after 3 washes with 1xIBS with secondary Goat Anti-
mouse IgG-AP conjugate (Novagen) for 1 hour and devel-
oped colorimetrically with BCIP/NBP substrate (KPL). For
quantification of expression, the cell extracts were probed
with a polyclonal rabbit anti-BCMO1 peptide antibody
(1:1,000 in 5% BSA in IBS) and then with the secondary
goat anti-rabbit IgG-HRP conjugate (Novagen) and the
ECL development (Amersham). The intensity of each
mutant BCMO1 band was quantified by densitometry
and normalized to the intensity of recombinant BCMO1
(0.1 μg) synthesized in the Roche RTS cell-free transcrip-
tion/translation system as a standard on each gel.
In vitro enzymatic activity assay
The in vitro assays for BCMO1 were performed following
the method of Lindqvist and Andersson [32] with small
modifications described previously [31]. Typically, reac-
tions were run in glass vials under reduced light in a vol-
ume of 200 μL in 100 mM Tricine-KOH (pH 8.0) buffer
supplemented with 10 μM FeSO4, 5 mM Tris(2-carboxye-
thyl)phosphine hydroxychloride (TCEP), 1% (w/v) 1-S-
octyl-β-d-thioglucopyranoside (OTG) and 10-20% (v/v)
glycerol. The enzyme concentration varied between 100
and 1600 ng/reaction, as determined by direct ELISA[31].
The concentration of β-carotene in the reaction mixture
ranged from 0.1 to 42 μM from a stock solution of 90
pmol/μL β-carotene (the solubility of β-carotene is a prob-
lem at higher concentrations). The substrate was solubi-
lized in hexane with 50 μL of 4% OTG in a glass vial, and
the solvent was evaporated under argon. The assay buffer
with substrate/detergent was preincubated at 37°C for 5
min, the enzyme in glycerol added, and the reaction incu-
bated at 37°C in water bath for 1 hour. To analyze reac-
tion products, we used a protocol modified from During
et al [61]. 50 μL of 37% (v/v) formaldehyde was added to
stop the reaction, and the incubation was continued for
10 min at 37°C. Then, 500 μL of acetonitrile was added,
the solution vortexed and put on ice at 4°C for 5 min. The
upper acetonitrile phase was collected and 100 μL injected
and analyzed by RP-HPLC.
HPLC analysis of carotenoids and all-trans retinal
β-carotene, all-trans retinal and β-apo-8'-carotenal (inter-
nal standard for in vivo assays) were separated on a 4.6 ×
250 mm 3 μm YMC C30 carotenoid column Waters, Inc.)
with a flow rate of 1 ml/min and simultaneous UV detec-
tion at 451 nm and 383 nm (Agilent 1100 HPLC), as
described previously with small modifications [31].
Briefly, the initial conditions consisted of 60:40 ace-
tonitrile/0.015 M NH4OAc held for 5 min, and followed
by a linear gradient to 50:50 isopropanol/acetonitrile in
10 min. This was held for an additional 10 min, and then
followed by a linear gradient to 80:20 isopropanol/ace-
tonitrile in 5 minutes and held for an additional 2 min-
utes before returning to initial conditions.
β-carotene and all-trans retinal were quantified from their
peak area using standard curves obtained with 2-220 ng
and 0.5-20 ng of material, respectively, in 60/40 ace-
tonitrile:lysis buffer.Page 10 of 13
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Tertiary structure modeling was done using SWISS-
MODEL (version 36.0003). This protein structure homol-
ogy-modeling server was accessed via the ExPASy web
server and/or locally from the program DeepView-Swiss-
PDB Viewer [62]. The template for modeling BCMO1 was
the structure of apocarotenal oxygenase (ACO) from Syn-
echocystis [11].
To mount the β-carotene molecule to the BCMO1 Swiss-
Pdb model the following simulation protocol was
applied. The DS ViewerPro 6.0 (Accelrys Software Inc.)
was used for visualization and initial operation with the
structures. Four histidine residues (His172, His234,
His308 and His514) are predicted to belong to the coor-
dination shell of Fe2+. This set of ligands was augmented
by a water molecule and the dioxygen molecule to form
the six-fold coordination shell of iron. The carotene mol-
ecule was then mounted manually by building its polyene
chain inside the available space and optimizing tempo-
rary geometry configurations by using the "Clean struc-
ture" procedure of DS ViewerPro 6.0. Finally, an
arrangement of the carotene species inside the protein
binding pocket was optimized by using the quantum
mechanical - molecular mechanical method [63].
Statistical analysis
Calculations of mean, variance and standard errors were
done using the Data Analysis Pack in Microsoft Office
Excel program.
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